Cargando…

Characteristics of T-Cell Receptor Repertoire and Correlation With EGFR Mutations in All Stages of Lung Cancer

Lung cancer is the leading cause of cancer-related deaths worldwide, and its occurrence is related to the accumulation of gene mutations and immune escape of the tumor. Sequencing of the T-cell receptor (TCR) repertoire can reveal the immunosurveillance status of the tumor microenvironment, which is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Huaxia, Wang, Yadong, Jia, Ziqi, Wang, Yanyu, Yang, Xiaoying, Wu, Pancheng, Song, Yang, Xu, Huihui, Gu, Dejian, Chen, Rongrong, Xia, Xuefeng, Bing, Zhongxing, Gao, Chao, Cao, Lei, Li, Shanqing, Cao, Zhili, Liang, Naixin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991722/ https://www.ncbi.nlm.nih.gov/pubmed/33777727 http://dx.doi.org/10.3389/fonc.2021.537735

Ejemplares similares

Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q
por: Song, Yang, et al.
Publicado: (2020)

Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer
por: Liang, Naixin, et al.
Publicado: (2022)

Pathological complete response to neoadjuvant ceritinib of a crizotinib‐resistant, stage IIIB non‐small cell lung cancer with ALK rearrangement: A case report
por: Bing, Zhongxing, et al.
Publicado: (2021)

Comprehensive analysis of T cell receptor repertoire in patients with KRAS mutant non-small cell lung cancer
por: Wang, Yadong, et al.
Publicado: (2022)

Survival and prognostic factors of lung cancer patients with preexisting connective tissue disease: a retrospective cohort study
por: Yang, Huaxia, et al.
Publicado: (2020)

Expression and prognostic analyses of ITGA11, ITGB4 and ITGB8 in human non-small cell lung cancer
por: Wu, Pancheng, et al.
Publicado: (2019)

Efficient isolation and quantification of circulating tumor cells in non-small cell lung cancer patients using peptide-functionalized magnetic nanoparticles
por: Liang, Naixin, et al.
Publicado: (2020)

Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma
por: Wu, Pancheng, et al.
Publicado: (2020)

First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up
por: Jia, Ziqi, et al.
Publicado: (2020)

Detection of Potential Mutated Genes Associated with Common Immunotherapy Biomarkers in Non-Small-Cell Lung Cancer Patients
por: Cao, Lei, et al.
Publicado: (2022)

Long noncoding RNA MALAT-1 is a novel inflammatory regulator in human systemic lupus erythematosus
por: Yang, Huaxia, et al.
Publicado: (2017)

Fatal Tumour Lysis Syndrome Induced by Brigatinib in a Lung Adenocarcinoma Patient Treated With Sequential ALK Inhibitors: A Case Report
por: Wang, Yadong, et al.
Publicado: (2021)

Temozolomide encapsulated and folic acid decorated chitosan nanoparticles for lung tumor targeting: improving therapeutic efficacy both in vitro and in vivo
por: Li, Kaidi, et al.
Publicado: (2017)

Determining EGFR-TKI sensitivity of G719X and other uncommon EGFR mutations in non-small cell lung cancer: Perplexity and solution
por: Li, Kaidi, et al.
Publicado: (2017)

Comprehensive genomic profiling aids in understanding the lesion origins of a patient with six synchronous invasive lung adenocarcinomas: a case study
por: Song, Yang, et al.
Publicado: (2020)

DNA methylation patterns at and beyond the histological margin of early-stage invasive lung adenocarcinoma radiologically manifested as pure ground-glass opacity
por: Jia, Ziqi, et al.
Publicado: (2021)

Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Combination Therapy as First-Line Treatment for Patients with Advanced EGFR-Mutated, Non-Small Cell Lung Cancer: A Systematic Review and Bayesian Network Meta-Analysis
por: Xue, Jianchao, et al.
Publicado: (2022)

Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation
por: Song, Yang, et al.
Publicado: (2023)

MicroRNA-539 Inhibits the Epithelial–Mesenchymal Transition of Esophageal Cancer Cells by Twist-Related Protein 1-Mediated Modulation of Melanoma-Associated Antigen A4
por: Cao, Zhili, et al.
Publicado: (2018)

Retraction notice to “MicroRNA-539 Inhibits the Epithelial-Mesenchymal Transition of Esophageal Cancer Cells by Twist-Related Protein 1-Mediated Modulation of Melanoma-Associated Antigen A4” [Oncology Research 26(4) (2018) 529-536]
por: Cao, Zhili, et al.
Publicado: (2021)

Machine Learning-Assisted Dual-Marker Detection in Serum Small Extracellular Vesicles for the Diagnosis and Prognosis Prediction of Non-Small Cell Lung Cancer
por: Li, Wenzhe, et al.
Publicado: (2022)

Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
por: Zhou, Xiaoxiang, et al.
Publicado: (2020)

The action mechanism of lncRNA-HOTAIR on the drug resistance of non-small cell lung cancer by regulating Wnt signaling pathway
por: Guo, Feng, et al.
Publicado: (2018)

Uncommon EGFR-Mutant NSCLC—One Drug Does Not Fit All
por: Wang, Yang, et al.
Publicado: (2023)

Safety and Efficacy of the Rechallenge of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer: A Systemic Review and Meta-Analysis
por: Zhao, Qing, et al.
Publicado: (2021)

HER2 transmembrane domain mutation: comprehensive characteristics and real-world evidence of treatment response in Chinese lung adenocarcinoma
por: Jia, Ziqi, et al.
Publicado: (2021)

Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations
por: Wei, Zhigang, et al.
Publicado: (2017)

Mature Red Blood Cells Contain Long DNA Fragments and Could Acquire DNA from Lung Cancer Tissue
por: Liang, Naixin, et al.
Publicado: (2023)

Antibody repertoire sequencing analysis: Antibody repertoire sequencing analysis
por: Zhang, Senxin, et al.
Publicado: (2022)

USP5 knockdown alleviates lung cancer progression via activating PARP1-mediated mTOR signaling pathway
por: Cao, Lei, et al.
Publicado: (2023)

Seabird’s cry: repertoire and vocal expression of contextual valence in the little auk (Alle alle)
por: Osiecka, Anna N., et al.
Publicado: (2023)

Polarization of ADAM17‐driven EGFR signalling in electric field‐guided collective migration of epidermal sheets
por: Jia, Naixin, et al.
Publicado: (2020)

Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia
por: Lin, Yan, et al.
Publicado: (2019)

Genetic and treatment profiles of patients with concurrent Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) mutations
por: Yang, Xiaodan, et al.
Publicado: (2021)

The Efficacy of Synchronous Combination of Chemotherapy and EGFR TKIs for the First-Line Treatment of NSCLC: A Systematic Analysis
por: Yan, Han, et al.
Publicado: (2015)

EGFR Testing Patterns and Detection of EGFR Exon 20 Insertions in the United States
por: Lin, Huamao M., et al.
Publicado: (2022)

Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors
por: Du, Xiaojing, et al.
Publicado: (2021)

A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib
por: Chen, Yan, et al.
Publicado: (2022)

KLF8 overexpression promotes the growth of human lung cancer cells by promoting the expression of JMJD2A
por: Ma, Dongjie, et al.
Publicado: (2019)

RNA-Seq and Immune Repertoire Analysis of Normal and Hepatocellular Carcinoma Relapse After Liver Transplantation
por: Guo, Fansheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0ogq4jqink0ttgcrc7a05hqdo7